Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

Clinical trial NCT01064505 · COMPLETED

Trial details

NCT number: NCT01064505
Sponsor: Quark Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Optic Atrophy Non-arteritic Anterior Ischemic Optic Neuropathy

Start date: 2010-02-01
Primary completion: 2013-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.